Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 ProteinKathleen Aertgeerts, Satoshi Sogabe, R.J. Skene et al.|Journal of Biological Chemistry|2011Cited by 441
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine ScaffoldTomoyasu Ishikawa, Keiji Kamiyama, Youichi Kawakita et al.|Journal of Medicinal Chemistry|2011Cited by 223
Structure-Based Approach for the Discovery of Pyrrolo[3,2-<i>d</i>]pyrimidine-Based EGFR T790M/L858R Mutant InhibitorsSatoshi Sogabe, Tomoyasu Ishikawa, Youichi Kawakita et al.|ACS Medicinal Chemistry Letters|2012Cited by 171
Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitorsYouichi Kawakita, Tomoyasu Ishikawa, Masaki Seto et al.|Bioorganic & Medicinal Chemistry|2013Cited by 79
Design and Synthesis of Pyrrolo[3,2-<i>d</i>]pyrimidine Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors: Exploration of Novel Back-Pocket BindersYouichi Kawakita, Tomoyasu Ishikawa, Hiroshi Banno et al.|Journal of Medicinal Chemistry|2012Cited by 44